
BeiGene, Ltd.
About BeiGene, Ltd.
BeiGene is a global biotechnology company discovering, developing, manufacturing and commercializing innovative oncology medicines. Its broad pipeline includes more than 50 clinical-stage molecules, spanning targeted therapy, immuno-oncology and combination regimens. Core products are BTK inhibitor BRUKINSA, PD-1 antibody tislelizumab and PARP inhibitor pamiparib, marketed worldwide through internal teams and strategic alliances. BeiGene operates integrated research campuses in Beijing and Cambridge, MA, a manufacturing facility in Suzhou and offices across North America, Europe and Asia-Pacific, serving patients in more than 45 countries.
Open Positions at BeiGene, Ltd.
1 month ago
1 month ago

BeiGene, Ltd.
2 months ago
2 months ago

BeiGene, Ltd.
2 months ago

BeiGene, Ltd.
2 months ago

BeiGene, Ltd.
2 months ago

BeiGene, Ltd.
2 months ago